Cargando…

Gender and racial bias in drug promotional material distributed by pharmaceutical companies

Detalles Bibliográficos
Autores principales:	Jaykaran, Yadav, Preeti, Kantharia, N. D., Saxena, Deepak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284038/ https://www.ncbi.nlm.nih.gov/pubmed/22368418 http://dx.doi.org/10.4103/0976-500X.92517

Ejemplares similares

Drug promotional literature distributed by pharmaceutical companies: Do they provide enough information to ascertain their validity?
por: Jaykaran,, et al.
Publicado: (2011)

Nonsignificant P values cannot prove null hypothesis: Absence of evidence is not evidence of absence
por: Jaykaran,, et al.
Publicado: (2011)

Clinical trials registered in clinical trial registry of India: A survey
por: Yadav, Preeti, et al.
Publicado: (2011)

Drug advertisements published in Indian Medical Journals: Are they ethical?
por: Charan, Jaykaran, et al.
Publicado: (2011)

Quality of Antidepressant Drugs Research Articles Published in Indian Medical Journals
por: Charan, Jaykaran, et al.
Publicado: (2011)

Reporting of method of animal sacrifice in articles published in Indian journals
por: Jaykaran,, et al.
Publicado: (2011)

Factors associated with performance of second year student in pharmacology examinations
por: Jaykaran,, et al.
Publicado: (2011)

Intern doctors’ feedback on teaching methodologies in pharmacology
por: Jaykaran,, et al.
Publicado: (2010)

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011)

Effect of Fluoxetine on Some Cognitive Functions of Patients of Depression
por: Jaykaran,, et al.
Publicado: (2009)

Expected Impact of Biosimilars on the Pharmaceutical Companies
por: Golshani, Shiva, et al.
Publicado: (2021)

Negative animal studies published in Indian Medical Journal: Are they methodologically strong enough to conclude what they are concluding?
por: Charan, Jaykaran, et al.
Publicado: (2014)

Antibiotics for the Treatment of Leptospirosis: Systematic Review and Meta-Analysis of Controlled Trials
por: Charan, Jaykaran, et al.
Publicado: (2013)

Gender bias in clinical research, pharmaceutical marketing, and the prescription of drugs
por: Chilet-Rosell, Elisa
Publicado: (2014)

Pharmaceutical companies as the funding sources for continuing medical education
por: Kanchan, Tanuj
Publicado: (2015)

Good Pharmacovigilance Practice: Accountability of Ayurvedic Pharmaceutical Companies
por: Sharma, Rohit, et al.
Publicado: (2017)

Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
por: Kobashi, Yurie, et al.
Publicado: (2019)

Vitamin D for prevention of respiratory tract infections: A systematic review and meta-analysis
por: Charan, Jaykaran, et al.
Publicado: (2012)

Editorial: Gender and Racial Bias in Sport Organizations
por: Cunningham, George B., et al.
Publicado: (2021)

Good pharmacovigilance practice: Need of the hour from pharmaceutical companies
por: Bhati, Neha, et al.
Publicado: (2015)

The influence of pharmaceutical companies
por: Migone, Paolo
Publicado: (2017)

Pharmacovigilance in pharmaceutical companies: An overview
por: Mammì, Maria, et al.
Publicado: (2013)

Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
por: Mitchell, Aaron P, et al.
Publicado: (2022)

How to calculate sample size in animal studies?
por: Charan, Jaykaran, et al.
Publicado: (2013)

Retraction Rates of Research Articles Addressing COVID-19 Pandemic: Is it the Evolving COVID Epidemiology or Scientific Misconduct?
por: Shah, Komal, et al.
Publicado: (2021)

Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history
por: Nagaich, Upendra, et al.
Publicado: (2015)

Pulse oximetry, racial bias and statistical bias: further improvements of pulse oximetry are necessary
por: Ferrari, Marco, et al.
Publicado: (2022)

Pharmacovigilance obligations of the pharmaceutical companies in India
por: Arora, Deepa
Publicado: (2008)

Involvement of pharmaceutical companies at scientific meetings
por: Brink, Andries
Publicado: (2010)

Regulating pharmaceutical companies’ financial largesse
por: Avraham, Ronen, et al.
Publicado: (2018)

The Pharmaceutical Company Approach to Antibiotic Policies
por: White, Anthony R.
Publicado: (2005)

Ethics, gastroenterologists, and pharmaceutical and equipment companies
por: Roberts‐Thomson, Ian C
Publicado: (2020)

Correction to: Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
Publicado: (2023)

Effects of fluoxetine and escitalopram on C-reactive protein in patients of depression
por: Chavda, Nilesh, et al.
Publicado: (2011)

Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan
por: Maeda, Hideki
Publicado: (2021)

Money talks—Philanthropists can foster gender and racial equity
por: Mizrahi, Romina
Publicado: (2019)

Excess Medicaid Payments and the Stock Prices of Drug Companies
por: Grant, William C.
Publicado: (2012)

Quality of reporting statistics in two Indian pharmacology journals
por: Jaykaran,, et al.
Publicado: (2011)

Pharmaceutical Company Targets and Strategies to Address Climate Change: Content Analysis of Public Reports from 20 Pharmaceutical Companies
por: Booth, Amy, et al.
Publicado: (2023)

Gender Bias in the Evaluation of Teaching Materials
por: Özgümüs, Asri, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o76qnvr7j1qrv32mr5k46d8gv9